Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

884
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
884
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

692
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
692
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

295
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
295
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

293
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
293
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

469
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
469

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Leptospiral uveitis: A late complication of systemic leptospirosis.

The Indian journal of medical research·2026
Same author

Fusicolla species as a rare cause of fungal endophthalmitis: A case report.

Diagnostic microbiology and infectious disease·2026
Same author

Trematode induced ocular granuloma in children from South India.

Indian journal of ophthalmology·2026
Same author

Emerging trends in parasitic uveitis due to Gnathostoma spinigerum: A case series and diagnostic challenge.

Indian journal of ophthalmology·2025
Same author

Geographic helicoid peripapillary choroidopathy: a photo essay.

Eye (London, England)·2024
Same author

Outer retinal deposits as initial manifestation of occipital B cell lymphoma: photo essay.

Eye (London, England)·2024

相关实验视频

Updated: Mar 13, 2026

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.3K

非传染性脑膜炎:使用生物药物进行治疗.

S R Rathinam1, Somanath Anjana

  • 1Uveitis Service, Aravind Eye Hospital and PG Institute of Ophthalmology, Madurai, Tamil Nadu, India.

Indian journal of ophthalmology
|March 12, 2026
PubMed
概括

生物药物,如抗瘤缩因子α (TNF-α) 疗法,在皮质类固醇失效时,为非传染性脑膜炎提供有效的治疗. 这些先进疗法有助于控制炎症,并预防耐火病例患者的视力丧失.

科学领域:

  • 眼科医生 眼科 眼科
  • 免疫学 免疫学 免疫学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 尿道炎是视力丧失的重要原因,涉及眼睛中层的炎症.
  • 皮质类固醇是非传染性脑膜炎的首要治疗方法,但对于耐火病例需要替代方案.

研究的目的:

  • 审查生物制剂在管理非传染性紫外线炎中的作用和有效性.
  • 以突出新兴的生物疗法,以治疗紫外线炎.

主要方法:

  • 对非传染性紫外线炎的生物药物研究的文献综述.
  • 对抗TNF-α药物和其他生物制剂的临床试验数据和病例报告的分析.

主要成果:

  • 抗瘤坏死因子α (TNF-α) 药物,如阿达利木马布,在治疗非传染性脑膜炎方面是有效的.
  • 其他生物药物,包括介质素和简氏激酶抑制剂,对脑膜炎的治疗有前途.

结论:

  • 生物药物是非传染性紫外线炎患者的有价值的替代品,不能容忍或耐受常规疗法.
  • 需要进一步的研究来证实生物治疗紫外线炎的长期安全性和有效性.
关键词:
这就是Adalimumab.雅努斯酶抑制剂的使用里图西马布 (Rituximab) 是一种药物.生物学是生物学的学科.非传染性紫外线炎.

更多相关视频

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.3K
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

1.1K

相关实验视频

Last Updated: Mar 13, 2026

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.3K
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.3K
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

1.1K